French JA - Search Results

1

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.

Thiele EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, Lyons PD, Taylor A, Roberts C, Sommerville K; GWPCARE4 Study Group. Thiele EA, et al. Among authors: french ja. Lancet. 2018 Mar 17;391(10125):1085-1096. doi: 10.1016/S0140-6736(18)30136-3. Epub 2018 Jan 26. Lancet. 2018. PMID: 29395273 Clinical Trial.

2

A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort.

French JA, Mosier M, Walker S, Sommerville K, Sussman N. French JA, et al. Neurology. 1996 Jan;46(1):54-61. doi: 10.1212/wnl.46.1.54. Neurology. 1996. PMID: 8559421 Clinical Trial.

3

Medical causes of seizures.

Delanty N, Vaughan CJ, French JA. Delanty N, et al. Among authors: french ja. Lancet. 1998 Aug 1;352(9125):383-90. doi: 10.1016/S0140-6736(98)02158-8. Lancet. 1998. PMID: 9717943 Free article. Review.

4

The etiology and diagnosis of status epilepticus.

Tatum Iv WO, French JA, Benbadis SR, Kaplan PW. Tatum Iv WO, et al. Among authors: french ja. Epilepsy Behav. 2001 Aug;2(4):311-7. doi: 10.1006/ebeh.2001.0195. Epilepsy Behav. 2001. PMID: 12609205

5

Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.

Friedman D, French JA. Friedman D, et al. Among authors: french ja. Neurology. 2006 Feb 28;66(4):590-1. doi: 10.1212/01.wnl.0000198500.84481.da. Neurology. 2006. PMID: 16505320

6

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.

French JA, Abou-Khalil BW, Leroy RF, Yacubian EM, Shin P, Hall S, Mansbach H, Nohria V; RESTORE 1/Study 301 Investigators. French JA, et al. Neurology. 2011 May 3;76(18):1555-63. doi: 10.1212/WNL.0b013e3182194bd3. Epub 2011 Mar 30. Neurology. 2011. PMID: 21451152 Clinical Trial.

7

Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions.

Friedman D, French JA. Friedman D, et al. Among authors: french ja. Lancet Neurol. 2012 Sep;11(9):827-34. doi: 10.1016/S1474-4422(12)70177-1. Lancet Neurol. 2012. PMID: 22898736

8

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.

French JA, Baroldi P, Brittain ST, Johnson JK; PROSPER Investigators Study Group. French JA, et al. Acta Neurol Scand. 2014 Mar;129(3):143-53. doi: 10.1111/ane.12207. Epub 2013 Dec 21. Acta Neurol Scand. 2014. PMID: 24359313 Free PMC article. Clinical Trial.

9

Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.

Rosenfeld W, Fountain NB, Kaubrys G, Ben-Menachem E, McShea C, Isojarvi J, Doty P; SP615 Study Investigators. Rosenfeld W, et al. Epilepsy Behav. 2014 Dec;41:164-70. doi: 10.1016/j.yebeh.2014.09.074. Epub 2014 Oct 27. Epilepsy Behav. 2014. PMID: 25461210 Clinical Trial.

10

Is a separate monotherapy indication warranted for antiepileptic drugs?

Mintzer S, French JA, Perucca E, Cramer JA, Messenheimer JA, Blum DE, Rogawski MA, Baulac M. Mintzer S, et al. Among authors: french ja. Lancet Neurol. 2015 Dec;14(12):1229-40. doi: 10.1016/S1474-4422(15)00229-X. Lancet Neurol. 2015. PMID: 26581972 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page